Molecular modeling and dynamics studies of Shikimate Kinase from Bacillus anthracis

Bioorganic & Medicinal Chemistry
Ivani PauliWalter Filgueira de Azevedo

Abstract

Bacillus anthracis has been used as weapon in bioterrorist activities, with high mortality, despite anti-microbial treatment, which strongly indicates a need of new drugs to treat anthrax. Shikimate Pathway is a seven-step biosynthetic route which generates chorismic acid. The shikimate pathway is essential for many pathological organisms, whereas it is absent in mammals. Therefore, these enzymes are potential targets for the development of non-toxic anti-microbial agents and herbicides and have been submitted to intensive structural studies. Shikimate Kinase is the fifth enzyme of shikimate pathway and catalyzes the specific phosphorylation of the 3-hydroxyl group of shikimate using ATP as a co-substrate, resulting in shikimate-3-phosphate and ADP. The present work describes for the first time a structural model for the Shikimate Kinase from B. anthracis using molecular modeling approach and molecular dynamics simulations. This study was able to identify the main residues of the ATP-binding and the shikimate pockets responsible for ligand affinities. Analysis of the molecular dynamics simulations indicates the structural features responsible for the stability of the structure. This study may help in the identification of new i...Continue Reading

References

Dec 1, 1993·Proteins·A AmadeiH J Berendsen
Feb 14, 2002·Trends in Biochemical Sciences·Ida SchomburgDietmar Schomburg
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Aug 25, 2004·Anesthesiology Clinics of North America·Alicia Gruber Kalamas
Mar 14, 2007·Current Drug Targets·Maurício Ribeiro MarquesMário Sérgio Palma
Mar 14, 2007·Current Drug Targets·José H PereiraDiógenes S Santos
Feb 9, 2008·Proteins·Helen A ArcuriWalter F de Azevedo

❮ Previous
Next ❯

Citations

Jan 28, 2009·Journal of Molecular Modeling·Ivani PauliWalter Filgueira de Azevedo
Mar 2, 2011·Journal of Molecular Recognition : JMR·Mahmoud Kandeel, Yukio Kitade

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
F M LaForce
Proceedings of the National Academy of Sciences of the United States of America
Stephen H Leppla
Human Vaccines
Diane R BienekRaymond E Biagini
© 2022 Meta ULC. All rights reserved